Credit Suisse’s BIND THERAPEUTICS INC BIND Stock Holding History

Credit Suisse’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-80,324	Closed	-$177K	–	4503
2016 Q1	$177K	Sell	80,324 -2,562	-3%	-$4.65K	﹤0.01%	3720
2015 Q4	$191K	Buy	82,886 +2,775	+3%	+$11.2K	﹤0.01%	3910
2015 Q3	$356K	Sell	80,111 -700	-0.9%	-$3.44K	﹤0.01%	3625
2015 Q2	$453K	Buy	80,811 +452	+0.6%	+$2.8K	﹤0.01%	3788
2015 Q1	$442K	Sell	80,359 -11,546	-13%	-$70.9K	﹤0.01%	3631
2014 Q4	$496K	Buy	91,905 +11,805	+15%	+$88.5K	﹤0.01%	3721
2014 Q3	$689K	Buy	80,100 +33,062	+70%	+$326K	﹤0.01%	3378
2014 Q2	$620K	Buy	47,038 +2,291	+5%	+$22.4K	﹤0.01%	3680
2014 Q1	$535K	Sell	44,747 -22,986	-34%	-$300K	﹤0.01%	3659
2013 Q4	$1.02M	Buy	+67,733	New	+$862K	﹤0.01%	3261

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Credit Suisse's BIND Position: Q2 2016 in Review

Credit Suisse sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 80,324 shares — an estimated $177K sold.

Credit Suisse first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $1.02M in Q4 2013. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

Credit Suisse reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
Credit Suisse sold 80,324 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $177K.
Credit Suisse first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
Credit Suisse's BIND THERAPEUTICS INC position peaked at $1.02M in Q4 2013.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.